Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity

Diabetes Res Clin Pract. 2020 Oct:168:108441. doi: 10.1016/j.diabres.2020.108441. Epub 2020 Sep 12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Diabetes Mellitus*
  • Glucocorticoids / adverse effects
  • Humans
  • Hyperglycemia* / chemically induced
  • Hyperglycemia* / epidemiology
  • Inpatients
  • Pandemics*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Glucocorticoids